Comparing the accumulation of active- and nonactive-site mutations in the HIV-1 protease

Biochemistry
José C ClementeBen M Dunn

Abstract

Protease inhibitor resistance still poses one of the greatest challenges in treating HIV. To better design inhibitors able to target resistant proteases, a deeper understanding is needed of the effects of accumulating mutations and the contributions of active- and nonactive-site mutations to the resistance. We have engineered a series of variants containing the nonactive-site mutations M46I and I54V and the active-site mutation I84V. These mutations were added to a protease clone (V6) isolated from a pediatric patient on ritonavir therapy. This variant possessed the ritonavir-resistance-associated mutations in the active-site (V32I and V82A) and nonactive-site mutations (K20R, L33F, M36I, L63P, A71V, and L90M). The I84V mutation had the greatest effect on decreasing catalytic efficiency, 10-fold when compared to the pretherapy clone LAI. The decrease in catalytic efficiency was partially recovered by the addition of mutations M46I and I54V. The M46I and I54V were just as effective at decreasing inhibitor binding as the I84V mutation when compared to V6 and LAI. The V6(54/84) variant showed over 1000-fold decrease in inhibitor-binding strength to ritonavir, indinavir, and nelfinavir when compared to LAI and V6. Crystal-structure...Continue Reading

References

Jan 1, 1985·Cell·S Wain-HobsonM Alizon
Jul 26, 1996·The Journal of Biological Chemistry·S PazhanisamyD J Livingston
Apr 25, 1997·Biochimica Et Biophysica Acta·S I WilsonJ Kay
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Aug 14, 1999·The Journal of Biological Chemistry·D B OlsenL C Kuo
Mar 10, 2000·Biochimica Et Biophysica Acta·A Wlodawer, A Gustchina
Mar 10, 2000·Biochimica Et Biophysica Acta·A G Tomasselli, R L Heinrikson
Sep 28, 2001·The Journal of Infectious Diseases·C F PernoUNKNOWN Italian Cohort Naive Antiretroviral (I.CO.N.A.) Study Group

❮ Previous
Next ❯

Citations

Sep 20, 2011·Chemical Reviews·Jeeyeon Lee, Nina M Goodey
Feb 3, 2012·Journal of the American Chemical Society·Seema MittalCelia A Schiffer
Jan 15, 2009·Journal of the American Chemical Society·Luis GalianoGail E Fanucci
Oct 1, 2009·Journal of the American Chemical Society·Jamie L KearGail E Fanucci
Jun 24, 2011·Journal of Biomolecular Structure & Dynamics·Rituraj PurohitRao Sethumadhavan
Oct 14, 2011·Viruses·Akbar AliCelia A Schiffer
Oct 23, 2015·Physical Chemistry Chemical Physics : PCCP·Zhanglong LiuGail E Fanucci
Jul 11, 2007·Expert Review of Molecular Diagnostics·Thorsteinn RögnvaldssonDaniel Garwicz
Oct 25, 2011·Chemico-biological Interactions·Jin XiangHong Ding
Aug 20, 2014·Journal of Chemical Theory and Computation·Yufeng CaiNese Kurt Yilmaz
Jun 19, 2008·Protein Science : a Publication of the Protein Society·Klára Grantz SaskováJan Konvalinka
Aug 26, 2010·Protein Science : a Publication of the Protein Society·Jane M SayerJohn M Louis
Feb 1, 2012·Angewandte Chemie·Arun K GhoshHiroaki Mitsuya
Jan 13, 2006·Journal of Molecular Biology·Holly HeasletC David Stout
Jan 15, 2013·Biochemical and Biophysical Research Communications·Zhigang LiuLadislau C Kovari
Oct 12, 2005·Structure·Alemayehu A Gorfe, Amedeo Caflisch
Apr 10, 2013·Biochemistry·Ian Mitchelle S de VeraGail E Fanucci
Apr 11, 2014·Journal of Virology·Madhavi KolliCelia A Schiffer
Apr 23, 2020·Future Medicinal Chemistry·Jurica NovakVladimir A Potemkin
Oct 1, 2008·Journal of Enzyme Inhibition and Medicinal Chemistry·Sandra KrauchencoIgor Polikarpov
May 25, 2021·Journal of Molecular Graphics & Modelling·Dean SherryYasien Sayed

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.